{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T12:13:46Z","timestamp":1788178426201,"version":"build-2803163510"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007560","name":"Chiesi Farmaceutici","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007560","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ejpb.2026.115202","type":"journal-article","created":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T23:27:57Z","timestamp":1785799677000},"page":"115202","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Engineering High-Performance Inhalable Monoclonal Antibody Powders via Spray Freeze Drying"],"prefix":"10.1016","volume":"227","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-5199-8282","authenticated-orcid":false,"given":"Lorena","family":"Pasero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adamo","family":"Sulpizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elettra","family":"Pinetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Sauli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-6420-7446","authenticated-orcid":false,"given":"Viola","family":"Geminati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Marenghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-1152-705X","authenticated-orcid":false,"given":"Giulia","family":"Carretta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-0572-2506","authenticated-orcid":false,"given":"Lara","family":"Benoldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomaso","family":"Guidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6990-3126","authenticated-orcid":false,"given":"Roberto","family":"Pisano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2026.115202_b0005","doi-asserted-by":"crossref","unstructured":"B. Kelley, \u201cThe history and potential future of monoclonal antibody therapeutics development and manufacturing in four eras,\u201d 2024, Taylor and Francis Ltd. doi: 10.1080\/19420862.2024.2373330.","DOI":"10.1080\/19420862.2024.2373330"},{"key":"10.1016\/j.ejpb.2026.115202_b0010","doi-asserted-by":"crossref","unstructured":"K. Berkenfeld et al., \u201cFormulation strategies, preparation methods, and devices for pulmonary delivery of biologics,\u201d Nov. 01, 2024, Elsevier B.V. doi: 10.1016\/j.ejpb.2024.114530.","DOI":"10.1016\/j.ejpb.2024.114530"},{"issue":"8","key":"10.1016\/j.ejpb.2026.115202_b0015","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.1021\/acs.molpharmaceut.9b00545","article-title":"Molecular Computations of Preferential Interaction Coefficients of IgG1 Monoclonal Antibodies with Sorbitol, Sucrose, and Trehalose and the Impact of These Excipients on Aggregation and Viscosity","volume":"16","author":"Cloutier","year":"2019","journal-title":"Mol. Pharm."},{"issue":"1","key":"10.1016\/j.ejpb.2026.115202_b0020","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1473-3099(23)00393-6","article-title":"Safety and efficacy of inhaled IBIO123 for mild-to-moderate COVID-19: a randomised, double-blind, dose-ascending, placebo-controlled, phase 1\/2 trial","volume":"24","author":"Maranda","year":"2024","journal-title":"Lancet Infect. Dis."},{"issue":"1","key":"10.1016\/j.ejpb.2026.115202_b0025","doi-asserted-by":"crossref","first-page":"Dec","DOI":"10.1038\/s41467-023-42440-x","article-title":"Aerosol delivery of SARS-CoV-2 human monoclonal antibodies in macaques limits viral replication and lung pathology","volume":"14","author":"Streblow","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejpb.2026.115202_b0030","first-page":"May","article-title":"A review on micro and nanoengineering in Powder-Based pulmonary drug delivery","volume":"p. 124248","author":"Pasero","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2026.115202_b0035","article-title":"\u201cDrug delivery to the lungs","author":"Newman","year":"2017","journal-title":"Challenges and opportunities\u201d"},{"key":"10.1016\/j.ejpb.2026.115202_b0040","doi-asserted-by":"crossref","unstructured":"Y. Guo, H. Bera, C. Shi, L. Zhang, D. Cun, and M. Yang, \u201cPharmaceutical strategies to extend pulmonary exposure of inhaled medicines,\u201d Aug. 01, 2021, Chinese Academy of Medical Sciences. doi: 10.1016\/j.apsb.2021.05.015.","DOI":"10.1016\/j.apsb.2021.05.015"},{"key":"10.1016\/j.ejpb.2026.115202_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2026.107446","article-title":"Minimizing aggregates when nebulizing antibody Fab fragments: high thermostability and high concentration are key","volume":"221","author":"Steinke","year":"2026","journal-title":"European Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.ejpb.2026.115202_b0050","doi-asserted-by":"crossref","unstructured":"K. Huang, T. Ying, and Y. Wu, \u201cSingle-Domain Antibodies as Therapeutics for Respiratory RNA Virus Infections,\u201d Jun. 01, 2022, MDPI. doi: 10.3390\/v14061162.","DOI":"10.3390\/v14061162"},{"key":"10.1016\/j.ejpb.2026.115202_b0055","doi-asserted-by":"crossref","unstructured":"J. G. Song, S. H. Lee, and H. K. Han, \u201cThe stabilization of biopharmaceuticals: current understanding and future perspectives,\u201d Nov. 01, 2017, Springer Netherlands. doi: 10.1007\/s40005-017-0341-9.","DOI":"10.1007\/s40005-017-0341-9"},{"issue":"11","key":"10.1016\/j.ejpb.2026.115202_b0060","doi-asserted-by":"crossref","first-page":"3096","DOI":"10.3390\/pr11113096","article-title":"Tailoring Dry Microparticles for Pulmonary Drug Delivery: Ultrasonic Spray Freeze-Drying with Mannitol and Salbutamol Sulphate","volume":"11","author":"Pasero","year":"2023","journal-title":"Processes"},{"key":"10.1016\/j.ejpb.2026.115202_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.powtec.2025.120788","article-title":"Spray freeze-drying for inhalable L-leucine, mannitol-based microparticles: The impact of process variables, L-leucine, and crystallinity on Aerosolization properties","volume":"455","author":"Pasero","year":"2025","journal-title":"Powder Technol."},{"issue":"9","key":"10.1016\/j.ejpb.2026.115202_b0070","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1007\/s11095-022-03331-w","article-title":"Spray-Dried and Spray-Freeze-Dried Powder Formulations of an Anti-Interleukin-4R\u03b1 Antibody for Pulmonary Delivery","volume":"39","author":"Pan","year":"2022","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2026.115202_b0075","doi-asserted-by":"crossref","unstructured":"Z. Liang, R. Ni, J. Zhou, and S. Mao, \u201cRecent advances in controlled pulmonary drug delivery,\u201d 2015. doi: 10.1016\/j.drudis.2014.09.020.","DOI":"10.1016\/j.drudis.2014.09.020"},{"key":"10.1016\/j.ejpb.2026.115202_b0080","doi-asserted-by":"crossref","unstructured":"W. Kaialy, M. Ticehurst, and A. Nokhodchi, \u201cDry powder inhalers: Mechanistic evaluation of lactose formulations containing salbutamol sulphate,\u201d Int. J. Pharm., vol. 423, no. 2, 2012, doi: 10.1016\/j.ijpharm.2011.12.018.","DOI":"10.1016\/j.ijpharm.2011.12.018"},{"key":"10.1016\/j.ejpb.2026.115202_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118901","article-title":"Particle engineered mannitol for carrier-based inhalation \u2013 A serious alternative?","volume":"577","author":"Hertel","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2026.115202_b0090","doi-asserted-by":"crossref","unstructured":"D. Zillen, M. Beugeling, W. L. J. Hinrichs, H. W. Frijlink, and F. Grasmeijer, \u201cNatural and bioinspired excipients for dry powder inhalation formulations,\u201d 2021. doi: 10.1016\/j.cocis.2021.101497.","DOI":"10.1016\/j.cocis.2021.101497"},{"issue":"5","key":"10.1016\/j.ejpb.2026.115202_b0095","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1208\/s12249-018-1023-2","article-title":"Spray-Freeze Drying: a Suitable Method for Aerosol Delivery of Antibodies in the Presence of Trehalose and Cyclodextrins","volume":"19","author":"Pouya","year":"2018","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejpb.2026.115202_b0100","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ejps.2018.04.013","article-title":"Effect of amino acids on the stability of spray freeze-dried immunoglobulin G in sugar-based matrices","volume":"119","author":"Emami","year":"2018","journal-title":"European Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.ejpb.2026.115202_b0105","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ejpb.2020.08.019","article-title":"Formulating monoclonal antibodies as powders for reconstitution at high concentration using spray-drying: Trehalose\/amino acid combinations as reconstitution time reducing and stability improving formulations","volume":"156","author":"Massant","year":"2020","journal-title":"European Journal of Pharmaceutics and Biopharmaceutics"},{"issue":"19","key":"10.1016\/j.ejpb.2026.115202_b0110","doi-asserted-by":"crossref","first-page":"Oct","DOI":"10.3390\/molecules27196497","article-title":"Polysorbates versus Hydroxypropyl Beta-Cyclodextrin (HP\u03b2CD): Comparative Study on Excipient Stability and Stabilization Benefits on Monoclonal Antibodies","volume":"27","author":"Zhang","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ejpb.2026.115202_b0115","doi-asserted-by":"crossref","unstructured":"N. R. Labiris and M. B. Dolovich, \u201cPulmonary drug delivery. Part II: The role of inhalant delivery devices and drug formulations in therapeutic effectiveness of aerosolized medications,\u201d 2003. doi: 10.1046\/j.1365-2125.2003.01893.x.","DOI":"10.1046\/j.1365-2125.2003.01893.x"},{"issue":"2","key":"10.1016\/j.ejpb.2026.115202_b0120","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.xphs.2021.08.022","article-title":"Identification of Stability Constraints in the Particle Engineering of an Inhaled Monoclonal Antibody Dried Powder","volume":"111","author":"Brunaugh","year":"2022","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2026.115202_b0125","doi-asserted-by":"crossref","unstructured":"F. Sonvico et al., \u201cRespicelltm: An innovative dissolution apparatus for inhaled products,\u201d Pharmaceutics, vol. 13, no. 10, Oct. 2021, doi: 10.3390\/pharmaceutics13101541.","DOI":"10.3390\/pharmaceutics13101541"},{"issue":"2","key":"10.1016\/j.ejpb.2026.115202_b0130","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1021\/acs.jproteome.4c00914","article-title":"Sequential MALDI-HiPLEX-IHC and Untargeted Spatial Proteomics Mass Spectrometry Imaging to Detect Proteomic Alterations Associated with Tumour Infiltrating Lymphocytes","volume":"24","author":"Bindi","year":"2025","journal-title":"J. Proteome Res."},{"issue":"4","key":"10.1016\/j.ejpb.2026.115202_b0135","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1021\/jasms.0c00473","article-title":"Highly Multiplexed Immunohistochemical MALDI-MS Imaging of Biomarkers in Tissues","volume":"32","author":"Yagnik","year":"2021","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"10.1016\/j.ejpb.2026.115202_b0140","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ejpb.2019.09.014","article-title":"The use of hydrophobic amino acids in protecting spray dried trehalose formulations against moisture-induced changes","volume":"144","author":"Mah","year":"2019","journal-title":"European Journal of Pharmaceutics and Biopharmaceutics"},{"key":"10.1016\/j.ejpb.2026.115202_b0145","doi-asserted-by":"crossref","unstructured":"N. Alhajj, N. J. O\u2019Reilly, and H. Cathcart, \u201cLeucine as an excipient in spray dried powder for inhalation,\u201d Oct. 01, 2021, Elsevier Ltd. doi: 10.1016\/j.drudis.2021.04.009.","DOI":"10.1016\/j.drudis.2021.04.009"},{"key":"10.1016\/j.ejpb.2026.115202_b0150","doi-asserted-by":"crossref","unstructured":"F. Fichtner, D. Mahlin, K. Welch, S. Gaisford, and G. Alderborn, \u201cEffect of surface energy on powder compactibility,\u201d in Pharmaceutical Research, Dec. 2008, pp. 2750\u20132759. doi: 10.1007\/s11095-008-9639-7.","DOI":"10.1007\/s11095-008-9639-7"},{"issue":"1","key":"10.1016\/j.ejpb.2026.115202_b0155","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3390\/pr14010006","article-title":"Controlling Mannitol Polymorphism for Enhanced Dispersibility in Spray Freeze-Dried Inhalable Microparticles","volume":"14","author":"Pasero","year":"2025","journal-title":"Processes"},{"key":"10.1016\/j.ejpb.2026.115202_b0160","article-title":"Amino acid-based stable adalimumab formulation in spray freeze-dried microparticles for pulmonary delivery","volume":"54","author":"Emami","year":"2019","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"5","key":"10.1016\/j.ejpb.2026.115202_b0165","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1021\/acs.biochem.2c00692","article-title":"How Sugars Protect Dry Protein Structure","volume":"62","author":"Brom","year":"2023","journal-title":"Biochemistry"},{"issue":"11","key":"10.1016\/j.ejpb.2026.115202_b0170","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1002\/bit.260431114","article-title":"Stabilizing effect of amphiphilic excipients on the freeze\u2010thawing and freeze\u2010drying of lactate dehydrogenase","volume":"43","author":"Izutsu","year":"1994","journal-title":"Biotechnol. Bioeng."},{"issue":"1","key":"10.1016\/j.ejpb.2026.115202_b0175","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3390\/pharmaceutics18010037","article-title":"Surfactant\u2013Particle Engineering Hybrids: Emerging Strategies for Enhancing Solubility and Oral Bioavailability of Poorly Water-Soluble Drugs","volume":"18","author":"Kim","year":"2025","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.ejpb.2026.115202_b0180","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/jps.21078","article-title":"Trileucine improves aerosol performance and stability of spray-dried powders for inhalation","volume":"97","author":"Lechuga-Ballesteros","year":"2008","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2026.115202_b0185","doi-asserted-by":"crossref","unstructured":"J. C. K. Lo, H. W. Pan, and J. K. W. Lam, \u201cInhalable protein powder prepared by spray-freeze-drying using hydroxypropyl-\u03b2-cyclodextrin as excipient,\u201d Pharmaceutics, vol. 13, no. 5, May 2021, doi: 10.3390\/pharmaceutics13050615.","DOI":"10.3390\/pharmaceutics13050615"},{"key":"10.1016\/j.ejpb.2026.115202_b0190","doi-asserted-by":"crossref","unstructured":"B. B. Eedara, R. Bastola, and S. C. Das, \u201cDissolution and Absorption of Inhaled Drug Particles in the Lungs,\u201d Dec. 01, 2022, MDPI. doi: 10.3390\/pharmaceutics14122667.","DOI":"10.3390\/pharmaceutics14122667"},{"key":"10.1016\/j.ejpb.2026.115202_b0195","doi-asserted-by":"crossref","unstructured":"J. S. Patton, \u201cMechanisms of macromolecule absorption by the lungs,\u201d 1996.","DOI":"10.1016\/0169-409X(95)00113-L"},{"key":"10.1016\/j.ejpb.2026.115202_b0200","doi-asserted-by":"crossref","unstructured":"J. S. Patton and P. R. Byron, \u201cInhaling medicines: Delivering drugs to the body through the lungs,\u201d Jan. 2007. doi: 10.1038\/nrd2153.","DOI":"10.1038\/nrd2153"},{"key":"10.1016\/j.ejpb.2026.115202_b0205","unstructured":"L. Guilleminault et al., \u201cFate of inhaled monoclonal antibodies after the deposition of aerosolized particles in the respiratory system\"."},{"issue":"10","key":"10.1016\/j.ejpb.2026.115202_b0210","doi-asserted-by":"crossref","first-page":"Oct","DOI":"10.3390\/pharmaceutics16101259","article-title":"Pulmonary Pharmacokinetics of Antibody and Antibody Fragments Following Systemic and Local Administration in Mice","volume":"16","author":"Jagdale","year":"2024","journal-title":"Pharmaceutics"}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641126002237?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641126002237?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T11:15:59Z","timestamp":1788174959000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641126002237"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":42,"alternative-id":["S0939641126002237"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2026.115202","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Engineering High-Performance Inhalable Monoclonal Antibody Powders via Spray Freeze Drying","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2026.115202","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"115202"}}